A dose-dense weekly schedule of paclitaxel (resulting in a greater frequency of drug delivery) plus carboplatin every 3 weeks or the addition of bevacizumab to paclitaxel and carboplatin administered ...

Inhibition of Wnt signaling as therapeutic option in platinum-resistant ovarian cancer.

In patients with triple-negative breast cancer (TNBC), adding once‑weekly carboplatin to standard neoadjuvant taxane‑anthracycline chemotherapy was associated with a significant improvement in overall ...